Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Clonazepam - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for clonazepam?

Clonazepam is the generic ingredient in three branded drugs marketed by Roche, Teva, Sun Pharm Inds Inc, Sandoz, Mylan Pharms Inc, Accord Hlthcare, Mylan, Prinston Inc, Watson Labs, Apotex Inc, Actavis Elizabeth, Par Pharm, and Barr, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for clonazepam. Forty-six suppliers are listed for this compound.

Summary for Generic Name: clonazepam

Tradenames:3
Patents:1
Applicants:13
NDAs:17
Drug Master File Entries: see list10
Suppliers / Packagers: see list46
Bulk Api Vendors: see list29
Clinical Trials: see list17
Patent Applications: see list5,333
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:clonazepam at DailyMed

Pharmacology for Ingredient: clonazepam

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth
CLONAZEPAM
clonazepam
TABLET;ORAL074869-003Oct 31, 1996RXNoNo► Subscribe► Subscribe
Mylan Pharms Inc
CLONAZEPAM
clonazepam
TABLET;ORAL074940-002Oct 30, 1997RXNoNo► Subscribe► Subscribe
Barr
CLONAZEPAM
clonazepam
TABLET, ORALLY DISINTEGRATING;ORAL077194-002Aug 10, 2005RXNoNo► Subscribe► Subscribe
Teva
CLONAZEPAM
clonazepam
TABLET;ORAL074569-003Sep 10, 1996RXNoNo► Subscribe► Subscribe
Roche
KLONOPIN
clonazepam
TABLET;ORAL017533-001Approved Prior to Jan 1, 1982RXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: clonazepam

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche
KLONOPIN RAPIDLY DISINTEGRATING
clonazepam
TABLET, ORALLY DISINTEGRATING;ORAL020813-003Dec 23, 19974,371,516► Subscribe
Roche
KLONOPIN RAPIDLY DISINTEGRATING
clonazepam
TABLET, ORALLY DISINTEGRATING;ORAL020813-001Dec 23, 19974,305,502► Subscribe
Roche
KLONOPIN
clonazepam
TABLET;ORAL017533-001Approved Prior to Jan 1, 19824,316,897► Subscribe
Roche
KLONOPIN RAPIDLY DISINTEGRATING
clonazepam
TABLET, ORALLY DISINTEGRATING;ORAL020813-002Dec 23, 19974,371,516► Subscribe
Roche
KLONOPIN
clonazepam
TABLET;ORAL017533-002Approved Prior to Jan 1, 19824,316,897► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc